Method for administration of capecitabine

Details for Australian Patent Application No. 2006228581 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Norton, Larry; Dugan, Ute

Agent Davies Collison Cave

Pub. Number AU-A-2006228581

PCT Pub. Number WO2006/103187

Priority 60/667,509 01.04.05 US

Filing date 22 March 2006

Wipo publication date 5 October 2006

International Classifications

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/103187 Priority application(s): WO2006/103187

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006228598-Connector housing assembly and method for housing a connector contact connecting a wire to a conducting lead in a piece of foil

2006228556-Reinforced concrete foundations